NINDS requests applications for developing novel drugs for disorders of the nervous system. This announcement is affiliated with the NIH Blueprint for Neuroscience Research.
The NIH Blueprint is a framework to enhance cooperative activities among 16 NIH Institutes, Centers, and Offices that support research on the nervous system.
Recent advances in neuroscience offer unprecedented opportunities to discover new treatments for nervous system disorders. However, most promising compounds identified through basic research are not sufficiently drug-like for human testing. To enable drug development by the neuroscience community, the NIH Blueprint is establishing a ‘virtual pharma’ network of contract service providers and consultants with extensive industry experience. This program intends to develop drugs from medicinal chemistry optimization through Phase I clinical testing and to facilitate industry partnerships for subsequent development of the drugs.
Letters of Intent Due November 15, 2011
Applications Due December 15, 2011
Potential applicants should contact Dr. Jill Heemskerk, program director, Office of Translational Research, NINDS, at 301-496-1779 or email@example.com; or Dr. Rebecca Farkas, program director, Office of Translational Research, NINDS, at 301-496-9271 or firstname.lastname@example.org. For more information visit http://grants.nih.gov/grants/guide/rfa-files/RFA-NS-12-002.html.